Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of PVA Hydrogel in Comparison With Synvisc-One®, in Patients With Knee Osteoarthritis

NCT04693104 is registered in ClinicalTrials.gov with Rottapharm Biotech as lead sponsor.

NCT NCT04693104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04693104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of PVA Hydrogel in Comparison With Synvisc-One®, in Patients With Knee Osteoarthritis
Lead sponsor
Rottapharm Biotech
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2019
Completion date
May 20, 2020
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis